Copyright
©The Author(s) 2022.
World J Orthop. Feb 18, 2022; 13(2): 178-192
Published online Feb 18, 2022. doi: 10.5312/wjo.v13.i2.178
Published online Feb 18, 2022. doi: 10.5312/wjo.v13.i2.178
Table 2 Patient characteristics
| Inclusion criteria | Exclusion criteria |
| Age ranging from 18 to 80 yr | Severe ankle malalignment (more than 5° varus or valgus) |
| Failed previous conservative treatment | Suspicion of grade two or higher (Kellgren-Lawrence-Score) ankle joint degeneration on the tibia side |
| Complaints for at least 6 mo | Ankle Fracture less than 6 mo ago |
| Talar osteochondral lesions (multiple degenerative talar cysts present, and/or prior failed operative treatment and/or multiple defects and/or a diameter of 15mm or more) | Tendinitis |
| Advanced osteoporosis | |
| Adiposity grade I (BMI of 30 kg/m2 or more) | |
| Diabetes mellitus / reumathoid arthritis / severe neuro-arthropathy | |
| Blood supply limitations and active infections, which may retard healing | |
| Foreign-body sensitivity | |
| Currently participating in an investigational drug or another device study that clinically interferes with the current study endpoints |
- Citation: Dahmen J, Altink JN, Vuurberg G, Wijdicks CA, Stufkens SA, Kerkhoffs GM. Clinical efficacy of the Ankle Spacer for the treatment of multiple secondary osteochondral lesions of the talus. World J Orthop 2022; 13(2): 178-192
- URL: https://www.wjgnet.com/2218-5836/full/v13/i2/178.htm
- DOI: https://dx.doi.org/10.5312/wjo.v13.i2.178